Kymera Therapeutics, Inc. Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kymera Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kymera Therapeutics, Inc. for March 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2021 | KYMR | Kymera Therapeutic ... | Booth Bruce | Director | Sell | S | 56.50 | 229,350 | 12,958,275 | 0 | 229.4 K to 0 (-100.00 %) |
| Mar 16 2021 | KYMR | Kymera Therapeutic ... | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 56.50 | 229,350 | 12,958,275 | 0 | 229.4 K to 0 (-100.00 %) |
| Mar 16 2021 | KYMR | Kymera Therapeutic ... | Ridloff Elena | Director | Option Exercise | A | 56.10 | 40,127 | 2,251,125 | 40,127 | |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Gollob Jared | Chief Medical Offic ... | Option Exercise | M | 1.31 | 7,800 | 10,218 | 60,007 | |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Gollob Jared | Chief Medical Offic ... | Option Exercise | M | 1.31 | 2,200 | 2,882 | 67,807 | |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Gollob Jared | Chief Medical Offic ... | Sell | S | 60.17 | 10,305 | 620,052 | 42,547 | 52.9 K to 42.5 K (-19.50 %) |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Gollob Jared | Chief Medical Offic ... | Buy | M | 1.31 | 7,800 | 10,218 | 52,852 | 45.1 K to 52.9 K (+17.31 %) |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Gollob Jared | Chief Medical Offic ... | Sell | S | 60.05 | 4,695 | 281,939 | 45,052 | 49.7 K to 45.1 K (-9.44 %) |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Gollob Jared | Chief Medical Offic ... | Buy | M | 1.31 | 2,200 | 2,882 | 49,747 | 47.5 K to 49.7 K (+4.63 %) |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Option Exercise | M | 2.08 | 8,195 | 17,046 | 234,061 | |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Option Exercise | M | 2.08 | 1,805 | 3,754 | 242,256 | |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Sell | S | 60.17 | 8,195 | 493,096 | 0 | 8.2 K to 0 (-100.00 %) |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Buy | M | 2.08 | 8,195 | 17,046 | 8,195 | 0 to 8.2 K |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Sell | S | 60.07 | 1,805 | 108,432 | 0 | 1.8 K to 0 (-100.00 %) |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Buy | M | 2.08 | 1,805 | 3,754 | 1,805 | 0 to 1.8 K |
| Mar 08 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Option Exercise | M | 2.08 | 10,000 | 20,800 | 244,061 | |
| Mar 08 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Sell | S | 52.15 | 1 | 52 | 0 | 1 to 0 (-100.00 %) |
| Mar 08 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Sell | S | 51.28 | 2,300 | 117,936 | 1 | 2.3 K to 1 (-99.96 %) |
| Mar 08 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Sell | S | 50.46 | 7,699 | 388,482 | 2,301 | 10 K to 2.3 K (-76.99 %) |
| Mar 08 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Buy | M | 2.08 | 10,000 | 20,800 | 10,000 | 0 to 10 K |
| Mar 05 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Option Exercise | M | 2.08 | 20,000 | 41,600 | 254,061 | |
| Mar 05 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Sell | S | 45.75 | 1,100 | 50,323 | 0 | 1.1 K to 0 (-100.00 %) |
| Mar 05 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Sell | S | 45.07 | 12,019 | 541,700 | 1,100 | 13.1 K to 1.1 K (-91.62 %) |
| Mar 05 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Sell | S | 44.12 | 6,881 | 303,611 | 13,119 | 20 K to 13.1 K (-34.40 %) |
| Mar 05 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Buy | M | 2.08 | 20,000 | 41,600 | 20,000 | 0 to 20 K |
| Mar 03 2021 | KYMR | Kymera Therapeutic ... | Gollob Jared | Chief Medical Offic ... | Option Exercise | A | 48.46 | 100,000 | 4,846,000 | 100,000 | |
| Mar 03 2021 | KYMR | Kymera Therapeutic ... | Chesworth Richard | Chief Scientific Of ... | Option Exercise | A | 48.46 | 60,000 | 2,907,600 | 60,000 | |
| Mar 03 2021 | KYMR | Kymera Therapeutic ... | Chesworth Richard | Chief Scientific Of ... | Option Exercise | A | 48.46 | 60,000 | 2,907,600 | 60,000 | |
| Mar 03 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Option Exercise | A | 48.46 | 140,000 | 6,784,400 | 140,000 |